Clinical Trial

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease

Study acronym: PPi-DIA
Recruiting
View on ClinicalTrials.gov →
Summary
The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-27 -> 2027-11-27 2026-07-28
minor Completion pushed: 2026-11-27 -> 2027-11-27 2026-07-28
Trial Details
NCT Number NCT06300788
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control
Enrollment 60 participants
Start Date 2024-05-27
Primary Completion 2027-11-27 (estimated)
Study Completion 2027-11-27 (estimated)
Updated on ClinicalTrials.gov 2026-07-27